Kopran's Q2 FY 2025-26 Quarterly Results

Result Summary

• Kopran Ltd reported a 14.4% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Sep (Q2 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a decline of 22.7%.
• Its expenses for the quarter were up by 1.3% QoQ and down 9.3% YoY.
• The net profit decreased 233.2% QoQ and decreased 234.4% YoY.
• The earnings per share (EPS) of Kopran Ltd declined at 2.06 during Q2 FY 2025-26.

Financial Statments for Q2 FY 2025-26

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Kopran Ltd is a company operating in the pharmaceutical industry. It primarily engages in the development, manufacturing, and marketing of a diverse range of pharmaceutical products. The company's product portfolio typically includes formulations and active pharmaceutical ingredients (APIs). Kopran Ltd is known for its focus on both domestic and international markets, providing healthcare solutions that adhere to stringent quality standards. As of the data available up to October 2023, there are no specific recent major developments available for Kopran Ltd.

Revenue

In the second quarter of fiscal year 2026 (Q2FY26), Kopran Ltd reported a total income of ₹117.93 crores. This represents a decline from the previous quarter (Q1FY26), where total income was ₹137.77 crores, reflecting a quarter-over-quarter (QoQ) decrease of 14.4%. Year-over-year (YoY) comparison shows a more significant decline, with total income falling by 22.7% from ₹152.56 crores in Q2FY25. The reduction in revenue both QoQ and YoY suggests significant challenges in maintaining income levels during this period.

Profitability

Kopran Ltd's profitability metrics show a notable downturn in Q2FY26. The company recorded a loss before tax of ₹11.63 crores, contrasting with a profit before tax of ₹9.89 crores in Q1FY26 and ₹9.64 crores in Q2FY25. This shift results in a substantial negative change of 217.6% QoQ and 220.6% YoY. Similarly, the profit after tax also turned negative, with a loss of ₹9.92 crores in Q2FY26, compared to profits of ₹7.45 crores in Q1FY26 and ₹7.38 crores in Q2FY25, marking declines of 233.2% QoQ and 234.4% YoY. Earnings per share mirrored this trend, registering at -₹2.06 for Q2FY26, down from ₹2.01 in Q1FY26 and ₹1.53 in Q2FY25, illustrating a decrease of 202.5% QoQ and 234.6% YoY.

Operating Metrics

The total expenses for Kopran Ltd in Q2FY26 amounted to ₹129.56 crores. This shows a slight increase of 1.3% compared to Q1FY26, where expenses were ₹127.89 crores, but a decrease of 9.3% compared to ₹142.90 crores in Q2FY25. Despite the QoQ increase, expenses did not decrease at the same rate as income, contributing to the negative profitability for the quarter. Tax expenses also shifted from ₹2.44 crores in Q1FY26 and ₹2.26 crores in Q2FY25 to a negative value of -₹1.70 crores in Q2FY26, indicating a reversal in tax obligations for the period. This overall performance highlights significant variations in the operational cost structure and tax liabilities during the quarter.